NEOPLASIA TREATMENT COMPOSITIONS CONTAINING ANTINEOPLASTIC AGENT AND SIDE-EFFECT REDUCING PROTECTIVE AGENT

摘要

C-2557 NEOPLASIA TREATMENT COMPOSITIONS CONTAINING ANTINEOPLASTIC AGENT AND SIDE-EFFECT REDUCING PROTECTIVE AGENT A combination chemotherapy for treatment of neoplastic diseases is described. Adverse cytotoxic side effects associated with antineoplastic agents may be reduced by the use of a cytoprotective copolymer in combination with the antineoplastic agent. A preferred combination chemotherapy uses doxorubicin to effect tumor remission along with carbetimer as a cytoprotective agent to reduce the toxic side effects associated with doxorubicin and to enhance the antineoplastic activity of doxorubicin.